Handok Inc. (KOSE:A002390) agreed to acquire an additional 16% stake in Genexine, Inc. (KOSDAQ:A095700) for KRW 25.8 billion on March 24, 2014. Under the terms of the transaction, Handok will acquire 1 million shares in the transaction to hold a total of 2.2 million shares in Genexine post transaction. Expected transaction settlement date is March 24, 2014.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,200 KRW | +1.12% | +0.56% | -27.27% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.27% | 216M | |
+11.93% | 116B | |
+13.01% | 106B | |
-9.17% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.49% | 16.33B | |
+6.70% | 14.14B | |
+31.07% | 12.02B |
- Stock Market
- Equities
- A095700 Stock
- News Genexine, Inc.
- Handok Inc. agreed to acquire an additional 16% stake in Genexine, Inc. for KRW 25.8 billion.